Eastgate Biotech Corp Increase (Decrease) in Long-term Receivables, Current
Eastgate Biotech Corp reported Increase (Decrease) in Long-term Receivables, Current of $17.63 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInLongTermReceivablesCurrent · last filed 2014-11-14
- 2013-09-30: Increase (Decrease) in Long-term Receivables, Current 9 month $17.63K.
| Period end | Increase (Decrease) in Long-term Receivables, Current 9 month |
|---|---|
| 2013-09-30 | $17.63K 10-Q · filed 2014-11-14 |